LH
LABCORP HOLDINGS INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 4 to Feb 19 ▲ 3 buys: April McClain Delaney, Anthony Wied bought, last disclosed Mar 12
- Mar 27 ▼ 2 insiders sell $660.1K at $267.05
- May 11 ▼ 1 insider sell $1.5M at $254.50
- Jun 8 ▼ 1 insider sell $201.1K at $263.89
- Jul 2 ▼ 2 insiders sell $93.3K at $286.19
- Aug 3 to Aug 17 ▼ 4 days of insider sells: $3.2M by 4 insiders, avg $316.83
- Aug 5 to Aug 7 ▼ 3 sells: April McClain Delaney sold $1,001 - $15,000, last disclosed Sep 10
- Oct 15 ▲ Labcorp agreed to acquire select assets of BioReference Health from…
- Oct 20 Seelig v. Labcorp Holdings Incorporated
- Oct 21 Dividend: Labcorp Declares Quarterly Dividend
- Oct 28 ▲ Labcorp reported Q3 2026 revenue of $3.81B, up 6.9% YoY, and adjuste…
- Oct 30 to Nov 10 ▼ 3 days of insider sells: $1.2M by 3 insiders, avg $366.93
Signal stack
Where each data set points today.
- InsidersBEARISH
9 insiders sold $6.9M.
- InstitutionsBULLISH
Q3 2026: 42 added (2 new), 26 trimmed or exited. Largest new: Hrt Financial $21.8M, Jump Financial $17.1M.
- AnalystsBULLISH
21 of 27 rate it Buy or better. Median target $395.50 (+7%).
- Short sellersSTEADY
Short interest −0.5% to 2.54M shares. 3.0 days to cover, ≈3.1% of shares.
- TrendUPTREND
12% above its 50-day average. New closing high $372.32 on Nov 12.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $1.1B |
| JPMORGAN CHASE & CO | TRIM | $259.2M |
| AMERICAN CENTURY COMPANIES INC | TRIM | $189.2M |
| Diamond Hill Capital Management, LLC (Investment Advisor) | TRIM | $138.6M |
| Amundi | TRIM | $126.2M |
| UBS Group AG | TRIM | $103.5M |
| FRANKLIN TEMPLETON INC | DOUBLED | $96.1M |
| CITIGROUP INC | ADD | $53.7M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
27 analystsPrice is inside the target range. Median implies +7%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 29, 2026 | UBS MAINTAIN | Buy |
| Oct 29, 2026 | Barclays MAINTAIN | Equal-Weight |
| Oct 29, 2026 | Truist Securities MAINTAIN | Buy |
| Oct 29, 2026 | Baird MAINTAIN | Outperform |
| Sep 21, 2026 | Truist Securities MAINTAIN | Buy |
| Sep 11, 2026 | UBS MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Caveney Brian J EVP, Pres of BLS, CMO & CSO Nov 10, 2026 | SELL | $744.1K |
Vaughn Bryan T EVP and President, Diagnostics Nov 3, 2026 | SELL | $108.2K |
Oyegunwa Akinbolade EVP, CIO & CTO Nov 2, 2026 | TAX W/H | $42.0K |
Vaughn Bryan T EVP and President, Diagnostics Nov 2, 2026 | TAX W/H | $69.0K |
Oyegunwa Akinbolade EVP, CIO & CTO Nov 1, 2026 | EXERCISE | 370 sh |
Vaughn Bryan T EVP and President, Diagnostics Nov 1, 2026 | EXERCISE | 500 sh |
Parham Richelle P Director Oct 30, 2026 | SELL | $389.4K |
Oyegunwa Akinbolade EVP, CIO & CTO Sep 1, 2026 | AWARD | 750 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
27 filings · 2 press releases · 3 bullish · 1 bearish · 23 neutral- NEUTRAL CLUSTERNov 12, 2026
Two Labcorp executives sold shares totaling $852K in the past week. EVP Caveney sold $744K in an…
The dollar amounts are negligible relative to market cap. Vaughn's sale was pre-planned; Caveney's was not but is still immaterial. No follow-up needed unless a larger pattern emerges.
- NEUTRAL 144Nov 10, 2026
Brian J. Caveney, an officer of Labcorp Holdings Inc., filed a Form 144 notice of intent to sell…
The sale is small relative to market cap and appears to be a routine diversification move by an officer. Monitor for any subsequent Form 4 filings to confirm execution and for any larger insider…
- NEUTRAL CLUSTERNov 5, 2026
Two insiders at Labcorp sold shares in the week following strong Q3 earnings and raised guidance…
Insider sales are immaterial in size and do not signal concern. Director Parham's sale without a plan is the only notable element, but the dollar amount is too small to be informative. Monitor next…
- NEUTRAL 144Nov 4, 2026
Megan D. Bailey, a former officer of Labcorp Holdings, filed a Form 144 notice of intent to sell…
The filing is a routine insider intent-to-sell notice with no material impact. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed.
All LH filing & press-release reports (29)
- CLUSTER reportNov 12, 2026
- 144 reportNov 10, 2026
- CLUSTER reportNov 5, 2026
- 144 reportNov 4, 2026
- 8-K reportNov 4, 2026
- 144 reportNov 3, 2026
- 144 reportOct 30, 2026
- 8-K reportOct 28, 2026
- INST-CLUSTER reportOct 26, 2026
- COURT-RULING reportOct 20, 2026
- 8-K reportOct 21, 2026
- PRESS-RELEASE reportOct 21, 2026
- PRESS-RELEASE reportOct 15, 2026
- 8-K reportSep 30, 2026
- 8-K reportSep 10, 2026
- 8-K reportAug 28, 2026
- CLUSTER reportAug 18, 2026
- 8-K reportAug 17, 2026
- 8-K reportAug 14, 2026
- CLUSTER reportAug 12, 2026
- CLUSTER reportAug 6, 2026
- 8-K reportJul 30, 2026
- 8-K reportJul 10, 2026
- 8-K reportJun 30, 2026
- 8-K reportApr 30, 2026
- DEFA14A reportApr 10, 2026
- 8-K reportApr 9, 2026
- CLUSTER reportFeb 24, 2026
- CLUSTER reportFeb 24, 2026